Deepak S.·Oct 22Moderna Stock Plunges 25% Following Early Cancer Vaccine Data Leak: What Investors Need to KnowThe biotechnology market experienced a sudden shock as shares of Moderna (NASDAQ: MRNA) plummeted by as much as 25%. The sharp sell-off was…
Andrii Kuzovchykov·Oct 4Moderna’s cancer vaccine worked. On October 24 we learn by how much.The first positive phase 3 for a personalized mRNA cancer vaccine disclosed no numbers, and the stock rose 177 percent anyway. Underneath…
OncoFrontier·Sep 16OpenAI Foundation Puts $40 Million Behind AI-Designed Cancer VaccinesA new grant to UNC Lineberger will fund the data and AI methods behind selecting the right tumour targets for personalised cancer vaccines
OncoFrontier·Aug 21A Personalised mRNA cancer vaccine reaches major milestone. What That Means in Reality.Merck and Moderna’s individualized neoantigen therapy met its primary endpoint in a Phase 3 melanoma trial, and AI played a central role in…
CancerFax - Advanced Cancer Treatment·Aug 21The Cancer Vaccine We’ve Been Waiting Decades For Might Have Just ArrivedI’ve spent years now sitting with patients and families as they try to make sense of complicated cancer treatment decisions, often under…
